Cargando…

DNMT3A mutants provide proliferating advantage with augmentation of self-renewal activity in the pathogenesis of AML in KMT2A-PTD-positive leukemic cells

Acute myeloid leukemia (AML) with partial tandem duplication of histone-lysine N-methyltransferase 2A (KMT2A-PTD) is a subtype of AML and is associated with adverse survival, yet the molecular pathogenesis of KMT2A-PTD is not fully understood. DNA methyltransferase 3A (DNMT3A) is mutated in various...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bera, Rabindranath, Chiu, Ming-Chun, Huang, Ying-Jung, Huang, Gang, Lee, Yun-Shien, Shih, Lee-Yung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997180/ https://www.ncbi.nlm.nih.gov/pubmed/32015320 http://dx.doi.org/10.1038/s41389-020-0191-6

Ejemplares similares

Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells
por: Bera, Rabindranath, et al.
Publicado: (2018)

The Landscape of KMT2A-PTD AML: Concurrent Mutations, Gene Expression Signatures, and Clinical Outcome
por: Hinai, Adil S.A. Al, et al.
Publicado: (2019)

Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD
por: Stasik, Sebastian, et al.
Publicado: (2022)

A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone
por: Hahn, C N, et al.
Publicado: (2015)

Prognostic significance of KMT2A-PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysis
por: Ye, Wu, et al.
Publicado: (2023)

Kmt2c mutations enhance HSC self-renewal capacity and convey a selective advantage after chemotherapy
por: Chen, Ran, et al.
Publicado: (2021)

Graphdiyne oxide nanosheets display selective anti-leukemia efficacy against DNMT3A-mutant AML cells
por: Wang, Qiwei, et al.
Publicado: (2022)

Controlling Pre-leukemic Thymocyte Self-Renewal
por: Goossens, Steven, et al.
Publicado: (2014)

PB1759: RETAINED FUNCTIONAL NORMAL AND/OR PRE-LEUKEMIC HSCS IN THE BONE MARROW ARE ASSOCIATED TO GOOD PROGNOSIS IN DNMT3AMUTNPM1MUT AML PATIENTS
por: Donato, Elisa, et al.
Publicado: (2023)

KMT2A-MLLT3 AML Masquerading as JMML may Disguise Fatal Leukemia
por: Saad, Ashraf Abdullah, et al.
Publicado: (2019)

Effects of protein transduction domain (PTD) selection and position for improved intracellular delivery of PTD-Hsp27 fusion protein formulations
por: Ul Ain, Qurrat, et al.
Publicado: (2016)

DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
por: Sato, Hanae, et al.
Publicado: (2016)

PtdIns(4,5)P(2) and PtdIns3P coordinate to regulate phagosomal sealing for apoptotic cell clearance
por: Cheng, Shiya, et al.
Publicado: (2015)

Low-dose salinomycin induces anti-leukemic responses in AML and MLL
por: Roulston, Gary D.R., et al.
Publicado: (2016)

Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML
por: Valent, Peter, et al.
Publicado: (2019)

DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1
por: Xu, Jie, et al.
Publicado: (2016)

PtdInsP(2) and PtdSer cooperate to trap synaptotagmin-1 to the plasma membrane in the presence of calcium
por: Pérez-Lara, Ángel, et al.
Publicado: (2016)

RDGBα, a PtdIns-PtdOH transfer protein, regulates G-protein-coupled PtdIns(4,5)P(2) signalling during Drosophila phototransduction
por: Yadav, Shweta, et al.
Publicado: (2015)

Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients
por: Yuan, Xiao-Qing, et al.
Publicado: (2016)

DNMT3A(R882)-associated hypomethylation patterns are maintained in primary AML xenografts, but not in the DNMT3A(R882C) OCI-AML3 leukemia cell line
por: Chen, David, et al.
Publicado: (2018)

RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
por: Bera, Rabindranath, et al.
Publicado: (2019)

Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML
por: Haubner, S., et al.
Publicado: (2018)

β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells
por: Zhao, Xin, et al.
Publicado: (2020)

DNMT1 Maintains Progenitor Function in Self-Renewing Somatic Tissue
por: Sen, George L., et al.
Publicado: (2010)

Probing PtdIns4P’s localization
por: Short, Ben
Publicado: (2014)

Lysophosphatidylinositol-Acyltransferase-1 (LPIAT1) Is Required to Maintain Physiological Levels of PtdIns and PtdInsP(2) in the Mouse
por: Anderson, Karen E., et al.
Publicado: (2013)

PtdIns4KIIα generates endosomal PtdIns(4)P and is required for receptor sorting at early endosomes
por: Henmi, Yuji, et al.
Publicado: (2016)

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
por: Menghrajani, Kamal, et al.
Publicado: (2022)

Bone Marrow Microenvironment-Induced Chemoprotection in KMT2A Rearranged Pediatric AML Is Overcome by Azacitidine–Panobinostat Combination
por: Lehner, Kara M., et al.
Publicado: (2023)

Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells
por: Trombly, Daniel J, et al.
Publicado: (2015)

Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4,5)P(2)
por: Hammond, Gerald R. V., et al.
Publicado: (2009)

STAT5-mediated self-renewal of normal hematopoietic and leukemic stem cells
por: Schepers, Hein, et al.
Publicado: (2012)

The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem Cells
por: Adane, Biniam, et al.
Publicado: (2019)

Epigenetic Modulation of Self-Renewal Capacity of Leukemic Stem Cells and Implications for Chemotherapy
por: Momparler, Richard L., et al.
Publicado: (2020)

Intracellular ATP Assay of Live Cells Using PTD-Conjugated Luciferase
por: Lee, Mi-Sook, et al.
Publicado: (2012)

RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with DNMT3A Mutations
por: Sidorova, Olga Alexandra, et al.
Publicado: (2022)

Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication
por: Antherieu, Gabriel, et al.
Publicado: (2021)

Novel PtdIns(3)P-binding protein Etf1 functions as an effector of the Vps34 PtdIns 3-kinase in autophagy
por: Wurmser, Andrew E., et al.
Publicado: (2002)

PtdIns4P recognition by Vps74/GOLPH3 links PtdIns 4-kinase signaling to retrograde Golgi trafficking
por: Wood, Christopher S., et al.
Publicado: (2009)

Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma
por: Maitituoheti, Mayinuer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9befsk2ftgb3e645ekol3gqpfu